HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

Clinical trial NCT02435901 · COMPLETED

Trial details

NCT number: NCT02435901
Sponsor: Northwell Health
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Beta Thalassemia-Major

Start date: 2008-12-01
Primary completion: 2019-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.